Suchergebnisse - "Nappi, Anna"

PubPharm (69)

41

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

enthalten in: BMC cancer | 2019

von Ottaiano, A. | Scala, S. | Normanno, N. | +30

42

Exploratory findings from a prematurely closed international, multicentre, academic trial : RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer

enthalten in: ESMO open | 2019

von Cardone, C. | Martinelli, E. | Troiani, T. | +15

43

Sickle cell diseases : What can nuclear medicine offer?

enthalten in: Hellenic journal of nuclear medicine | 2019

von Niccoli Asabella, A. | Altini, C. | Nappi, A. | +5

44

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients : a real practice study with long-term outcome and prognostic factors

enthalten in: Oncotarget | 2018

von Ottaiano, A. | Scotti, V. | De Divitiis, C. | +12

45

Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology : An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

enthalten in: Frontiers in public health | 2018

von Capozzi, M. | De Divitiis, C. | Ottaiano, A. | +13

46

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer : Anti-EGFR or Bevacizumab? Results From a Meta-Analysis

enthalten in: Frontiers in pharmacology | 2018

von Ottaiano, A. | De Stefano, A. | Capozzi, M. | +11

47

Metastatic Colorectal Cancer : Role of Target Therapies and Future Perspectives

enthalten in: Current cancer drug targets | 2018

von Nappi, A. | Berretta, M. | Romano, C. | +9

48

Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives

enthalten in: Current cancer drug targets | 2018

von Nappi, A. | Berretta, M. | Romano, C. | +9

49

Adherence and safety of regorafenib for patients with metastatic colorectal cancer : observational real-life study

enthalten in: Future oncology (London, England) | 2017

von Del Prete, S. | Cennamo, G. | Leo, L. | +10

50

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment

enthalten in: ESMO open | 2017

von Martinelli, E. | Sforza, V. | Cardone, C. | +16

CommentIn: ESMO Open. 2017 Jul 29;2(3):e000205. - PMID 29303156